It was only when AMPK-mediated signaling succumbed to progressive ROS/JNK-mediated hepatocellular injury in the CHIP−/−-mouse liver, that the microvesicular steatosis yielded to the full-blown pathognomonic signs of NASH [29]. The gene discussed is PRKAA1; the disease is metabolic dysfunction-associated steatohepatitis.